Clinical trials · Illinois
Neoplasms by Site clinical trials in Illinois
We’re tracking 6 recruiting neoplasms by site studies with a site in Illinois — including Phase 1, Phase 1/Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Illinois
- NCT05386108RecruitingPhase 1/Phase 2
Test abemaciclib plus elacestrant for breast cancer brain spread
This trial studies whether the combination of abemaciclib and elacestrant can slow or shrink ER-positive, HER2-negative breast cancer that has spread to the brain. It is designed for people whose cancer has progressed despite prior hormone (endocrine) treatment.
Urbana, IllinoisAges 18 years+ - NCT07222800RecruitingPhase 3
Testing a new drug plus chemo for stage 4 colorectal cancer
This study tests a new experimental drug (PF-08634404) combined with standard chemotherapy for people with stage 4 colorectal cancer who have not yet been treated for their advanced disease. The goal is to see if the combination helps shrink or slow the growth of tumors.
Arlington Heights, IllinoisAges 18 years+ - NCT04572451RecruitingPhase 1
Radiation with two antibody drugs for advanced, metastatic cancers
This early-phase trial tests whether a focused type of radiation (SBRT) given with anti–PD-1 and an anti–IL-8 antibody is safe in people with advanced cancers that have spread. It also looks for whether this combination might help control tumors at a few treatable spots.
Chicago, IllinoisAges 18 years+ - NCT06072612RecruitingPhase 3
Bria-IMT plus CPI vs standard care for advanced breast cancer
This trial tests a new combination of two immunotherapy drugs (Bria-IMT and a checkpoint inhibitor) against your doctor's choice of standard treatments. It is for people with advanced breast cancer that has spread and who have already tried several prior therapies.
Urbana, IllinoisAges 18 years+ - NCT07387445Recruiting
Time-Restricted Eating During Breast Cancer Chemotherapy
This trial tests whether eating only during certain hours of the day (time-restricted eating) is doable and helpful for people receiving chemotherapy for breast cancer. The goal is to see if this eating pattern can be a safe way to support your health during treatment.
Chicago, IllinoisAges 25–99 - NCT04804644RecruitingPhase 3
Memory-sparing radiation for brain metastases in small cell lung cancer
This study tests whether focusing high-dose radiation only on brain tumor spots, while avoiding the hippocampus (a brain area important for memory), helps protect memory and thinking compared with standard whole-brain radiation. It’s for people with small cell lung cancer that has spread to the brain.
O'Fallon, IllinoisAges 18 years+
Where these studies are running in Illinois
Institutions with a site for the recruiting neoplasms by site studies listed above.
- Carle Cancer Center · 3 studies
- Northwestern University · 2 studies
- University of Chicago · 2 studies
- Cancer Care Center of O'Fallon
- Cancer Care Specialists of Illinois - Decatur
- Carle at The Riverfront
- Carle Physician Group-Effingham
- Carle Physician Group-Mattoon/Charleston
What taking part in a neoplasms by site study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Neoplasms by Site trials in other states
Common questions
- Are there neoplasms by site clinical trials in Illinois?
- Yes. We're currently tracking 6 recruiting neoplasms by site studies with a site in Illinois, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a neoplasms by site study in Illinois?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Illinois to take part?
- Not necessarily. These studies have a site in Illinois, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a neoplasms by site trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New neoplasms by site studies open in Illinois regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.